Meto logo

Meto Review

7.4
★★★★☆3.7/5
No longer offers GLP-1s; the site now sells peptide therapy

Meto is no longer available as we reviewed it, so this page is kept for reference.

Meto: No longer offers GLP-1s; the site now sells peptide therapy. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.

See our top-rated GLP-1 providers →
Compare top-rated alternatives ↓

Meto is an insurance-accepting metabolic telehealth platform offering compounded semaglutide and compounded tirzepatide, prescribed after clinician-ordered lab work. The platform matches patients with board-certified specialists (including endocrinologists, obesity medicine physicians, dietitians, and metabolic health coaches) within minutes, and manages all billing, prior-authorization, and insurance paperwork for major insurers (Blue Cross, Anthem, United Healthcare, Aetna). Most insured patients pay $0–50 per visit; self-pay rates exist but are not publicly disclosed.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Insurance AcceptedCompoundedSemaglutideTirzepatideLab Monitoring RequiredInjectionsAll 50 StatesMetabolic Specialist Matching

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Meto

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Meto logo
3.7 / 5
Our editorial rating

Meto at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
What's included
Medication · Consult · Labs · Coaching
FDA status
No FDA warning letter on record

How we scored Meto

Each dimension is scored algorithmically from Meto’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.3/10

Meto no longer sells GLP-1 treatment, so no current price applies.

Effectiveness25%

8.1/10

Meto offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.4/10

Online intake and platform experience (consult included in the price); 8 platform features disclosed.

Trust & Safety15%

7.3/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

8.6/10

Meto treats patients in all 50 states. Insurance pathways are offered for eligible patients.

Support10%

7.2/10

Coaching/dietitian access included.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Meto review

Last checked August 2026
  • Noted its stated service area; it publishes no state-by-state list
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Meto

We walked Meto’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Start with an online assessment via Meto's intake quiz.
  2. 2Choose your path: a targeted treatment plan, a diagnostic test package, or a consult.
  3. 3Get a personalized medical plan from a provider.
  4. 4Follow your progress over time.
Price shown only after intake
  • Insurance-oriented model: average session cost with insurance stated as $25, most visits $0-50 with insurance.
  • No explicit monthly medication/subscription price is shown before intake.
  • Lab testing is optional; diagnostic panels range $199-$399.
  • Virtual visits are said to be accepted by major insurers.
  • Support appears email-only with no phone number or hours listed.

Meto customer support

GLP-1 medications Meto offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Peptides Meto offers

Beyond GLP-1s, Meto also offers these peptides. Tap any for our evidence-based guide.

What we like

  • Accepts major insurance (Blue Cross, Anthem, United, Aetna), and most patients pay $0–50 per visit
  • Requires lab work before prescribing GLP-1s; addresses root-cause metabolic drivers
  • Matches patients with endocrinologists and obesity medicine specialists within minutes
  • Offers compounded semaglutide and tirzepatide with board-certified physician oversight
  • Handles all prior-auth paperwork; provider location pages exist for all 50 US states

Watch-outs

  • Medication pricing shows only after the quiz, with no public cash price for semaglutide or tirzepatide
  • Lab panels are a separate out-of-pocket cost ($199–$399) unless covered by insurance
  • No LegitScript certification or named compounding pharmacy found on any public page
  • Company leadership and clinical team not disclosed publicly
  • The site says self-pay cash pricing exists, but it is not published anywhere

Is Meto still an option?

Meto no longer offers a GLP-1 weight-loss program, so there is nothing to sign up for today. We cannot quote a current price, because none exists. We keep this page online so past users can see what it offered and find a program that still operates.

If you were a Meto patient, talk with your prescriber before your remaining supply runs out. That keeps treatment going without a gap or an unsafe restart dose. Then compare current providers on price, medication and state coverage. Our page of Meto alternatives lists programs that still operate, and the ranked list of semaglutide providers shows where each one stands. If you need a new prescription, our guide on how to get a GLP-1 prescription walks through the steps.

The Bottom Line

Meto is no longer available as we reviewed it, so this page is kept for reference.

Score: 7.4/10Best for: insurance-accepting metabolic telehealth with compounded GLP-1

Frequently Asked Questions

Meto is an insurance-accepting metabolic telehealth platform that matches you with board-certified specialists such as endocrinologists, obesity medicine physicians, and dietitians, who order lab work and, if appropriate, prescribe compounded semaglutide or tirzepatide. A licensed clinician determines whether treatment is appropriate based on your labs and clinical data.
Meto offers injectable compounded semaglutide and tirzepatide alongside lab-based metabolic evaluation, specialist matching, and coaching support. Compounded medications are not FDA-approved and are prepared by a compounding pharmacy.
Yes. Providers order labs tailored to your needs before prescribing GLP-1 therapy. Standalone lab panels range from about $199 to $399 (for example, a comprehensive metabolic panel at $199) and may be covered by insurance, but they are a separate cost from any medication.
Meto is in-network with major insurers including Blue Cross, Anthem, United Healthcare, and Aetna, and states that most insured patients pay $0-50 per visit. Self-pay cash-pay rates exist but are not published, and medication pricing is shown only after you complete the intake quiz.
Meto maintains provider pages for all 50 US states, indicating nationwide availability. Confirm that a matching specialist is licensed in your state when you sign up.
You complete an online quiz and intake, after which Meto matches you with a metabolic specialist and handles billing, prior authorization, and insurance paperwork. Medication and specific pricing are presented after that intake.
Meto is not an option for new weight-loss patients now (no longer offers GLP-1s; the site now sells peptide therapy). We found no FDA warning letter on file for it.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Meto. The concerns our review flags: Medication pricing shows only after the quiz, with no public cash price for semaglutide or tirzepatide; Lab panels are a separate out-of-pocket cost ($199–$399) unless covered by insurance; No LegitScript certification or named compounding pharmacy found on any public page; Company leadership and clinical team not disclosed publicly. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Meto review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.